{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:13:43Z","timestamp":1790273623937,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]},{"name":"The Ministry of Health and Medical Education, Iran","award":["97000071"],"award-info":[{"award-number":["97000071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22784-3","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:47:56Z","timestamp":1774439276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A decade of change: trends in drug and alcohol use in Iran (2010\u20132019)"],"prefix":"10.1186","volume":"26","author":[{"given":"Saiedeh","family":"Haji-Maghsoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Rastegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Haghdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hajebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Ghoddousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toktam Khojasteh","family":"Bojnourdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Baneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"5","key":"22784_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2105\/AJPH.2020.306149","volume":"111","author":"D Holtzman","year":"2021","unstructured":"Holtzman D, Asher AK, Schillie S. The changing epidemiology of hepatitis C virus infection in the united States during the years 2010 to 2018. Am J Public Health. 2021;111(5):949\u201355.","journal-title":"Am J Public Health"},{"issue":"Suppl 5","key":"22784_CR2","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","volume":"222","author":"A Levitt","year":"2020","unstructured":"Levitt A, Mermin J, Jones CM, See I, Butler JC. Infectious diseases and injection drug use: public health burden and response. J Infect Dis. 2020;222(Suppl 5):S213\u20137.","journal-title":"J Infect Dis"},{"key":"22784_CR3","doi-asserted-by":"publisher","first-page":"108162","DOI":"10.1016\/j.drugalcdep.2020.108162","volume":"214","author":"RD Shearer","year":"2020","unstructured":"Shearer RD, Howell BA, Bart G, Winkelman TN. Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015\u20132018. Drug Alcohol Depend. 2020;214:108162.","journal-title":"Drug Alcohol Depend"},{"key":"22784_CR4","unstructured":"UNODC: World Drug Report. 2024. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html (accessed September 25, 2024). United Nations Office on Drugs and Crime 2024."},{"key":"22784_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2017.02.018","volume":"176","author":"M Amin-Esmaeili","year":"2017","unstructured":"Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Mojtabai R, Radgoodarzi R, Hefazi M, Motevalian A. Alcohol use disorders in Iran: prevalence, symptoms, correlates, and comorbidity. Drug Alcohol Depend. 2017;176:48\u201354.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"22784_CR6","doi-asserted-by":"publisher","first-page":"e0001216","DOI":"10.1371\/journal.pgph.0001216","volume":"3","author":"A Beksinska","year":"2023","unstructured":"Beksinska A, Karlsen O, Gafos M, Beattie TS. Alcohol use and associated risk factors among female sex workers in low-and middle-income countries: A systematic review and meta-analysis. PLOS Global Public Health. 2023;3(6):e0001216.","journal-title":"PLOS Global Public Health"},{"key":"22784_CR7","doi-asserted-by":"crossref","unstructured":"Esser MB. Deaths and years of potential life lost from excessive alcohol use\u2014United States, 2011\u20132015. MMWR Morbidity and mortality weekly report 2020, 69.","DOI":"10.15585\/mmwr.mm6939a5"},{"issue":"5","key":"22784_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1360-0443.2010.02899.x","volume":"105","author":"J Rehm","year":"2010","unstructured":"Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, Parry CD, Patra J, Popova S, Poznyak V. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817\u201343.","journal-title":"Addiction"},{"key":"22784_CR9","first-page":"6578","volume":"12","author":"A Rastegari","year":"2023","unstructured":"Rastegari A, Baneshi MR, Hajebi A, Noroozi A, Karamouzian M, Shokoohi M, Mirzazadeh A, Khojasteh Bojnourdi T, Nasiri N, Haji Maghsoudi S, et al. Population size Estimation of people who use illicit drugs and alcohol in Iran (2015\u20132016). Int J Health Policy Manag. 2023;12:6578.","journal-title":"Int J Health Policy Manag"},{"issue":"8","key":"22784_CR10","first-page":"480","volume":"18","author":"B Moazen","year":"2015","unstructured":"Moazen B, Shokoohi M, Noori A, Rahimzadeh S, Saeedi Moghaddam S, Rezaei F, Lotfizadeh M, Kazemi MR, Jamshidi HR, Pazhuheian F, et al. Burden of drug and alcohol use disorders in Iran: findings from the global burden of disease study 2010. Arch Iran Med. 2015;18(8):480\u20135.","journal-title":"Arch Iran Med"},{"issue":"12","key":"22784_CR11","first-page":"406","volume":"5","author":"UPADHYAY AK","year":"2018","unstructured":"UPADHYAY AK. Drug trafficking in the world. Int J Appl Social Sci. 2018;5(12):406\u20132413.","journal-title":"Int J Appl Social Sci"},{"key":"22784_CR12","unstructured":"Fazli S. The Impact of Afghanistan\u2018s Drug Trade on its Neighbours. In.: Research Report; 2023."},{"key":"22784_CR13","doi-asserted-by":"crossref","unstructured":"Ghiabi M. Drugs politics: managing disorder in the Islamic Republic of Iran. Cambridge University Press; 2019.","DOI":"10.21428\/cb6ab371.aeaf3a99"},{"issue":"2","key":"22784_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/14659891.2019.1664670","volume":"25","author":"M Roshanpajouh","year":"2020","unstructured":"Roshanpajouh M, Mirkazemi R, Ehterami M, Narenjiha H, Malek Afzali H, Sarrami HR, Rezazade M. Drug use among Iranian population: results of a National household survey. J Subst Use. 2020;25(2):146\u201351.","journal-title":"J Subst Use"},{"issue":"Suppl 2Suppl2","key":"22784_CR15","first-page":"ii11","volume":"86","author":"HR Bernard","year":"2010","unstructured":"Bernard HR, Hallett T, Iovita A, Johnsen EC, Lyerla R, McCarty C, Mahy M, Salganik MJ, Saliuk T, Scutelniciuc O, et al. Counting hard-to-count populations: the network scale-up method for public health. Sex Transm Infect. 2010;86(Suppl 2Suppl2):ii11\u201315.","journal-title":"Sex Transm Infect"},{"key":"22784_CR16","unstructured":"Mahy M. Network scale-up: a promising method for National estimates of the sizes of populations at higher risk, UNAIDS quarterly update on HIV epidemiology. In.; 2010."},{"issue":"8","key":"22784_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/sextrans-2018-053747","volume":"95","author":"AKJ Teo","year":"2019","unstructured":"Teo AKJ, Prem K, Chen MIC, Roellin A, Wong ML, La HH, Cook AR. Estimating the size of key populations for HIV in Singapore using the network scale-up method. Sex Transm Infect. 2019;95(8):602\u20137.","journal-title":"Sex Transm Infect"},{"key":"22784_CR18","doi-asserted-by":"publisher","first-page":"e2018041","DOI":"10.4178\/epih.e2018041","volume":"40","author":"A Haghdoost","year":"2018","unstructured":"Haghdoost A, Ahmadi Gohari M, Mirzazadeh A, Zolala F, Baneshi MR. A review of methods to estimate the visibility factor for bias correction in network scale-up studies. Epidemiol Health. 2018;40:e2018041.","journal-title":"Epidemiol Health"},{"issue":"11","key":"22784_CR19","doi-asserted-by":"publisher","first-page":"e110917","DOI":"10.1371\/journal.pone.0110917","volume":"9","author":"A Maghsoudi","year":"2014","unstructured":"Maghsoudi A, Baneshi MR, Neydavoodi M, Haghdoost A. Network scale-up correction factors for population size Estimation of people who inject drugs and female sex workers in Iran. PLoS ONE. 2014;9(11):e110917.","journal-title":"PLoS ONE"},{"key":"22784_CR20","doi-asserted-by":"crossref","unstructured":"Jami MA, Baneshi M, Nasirian M. Population size Estimation of high-risk behavior in Isfahan, Iran: using the network scale-up method in 2018. J Biostatistics Epidemiol 2021.","DOI":"10.18502\/jbe.v7i2.6711"},{"issue":"3\u20134","key":"22784_CR21","first-page":"81","volume":"2","author":"M Shokoohi","year":"2010","unstructured":"Shokoohi M, Baneshi MR, Haghdoost AA. Estimation of the active network size of Kermanian males. Addict Health. 2010;2(3\u20134):81\u20138.","journal-title":"Addict Health"},{"issue":"3","key":"22784_CR22","first-page":"170","volume":"8","author":"M Zamanian","year":"2016","unstructured":"Zamanian M, Baneshi MR, Haghdoost AA, Mokhtari-Sorkhani T, Amiri F, Zolala F. Estimating the size and age-gender distribution of women\u2019s active social networks. Addict Health. 2016;8(3):170.","journal-title":"Addict Health"},{"issue":"1","key":"22784_CR23","first-page":"18","volume":"12","author":"MR Baneshi","year":"2020","unstructured":"Baneshi MR, Zolala F, Zamanian M, Zarei N, Heydari MR. Estimating the visibility rate of alcohol consumption: A case study in Shiraz, Iran. Addict Health. 2020;12(1):18\u201324.","journal-title":"Addict Health"},{"issue":"3","key":"22784_CR24","first-page":"646","volume":"52","author":"MA Gohari","year":"2023","unstructured":"Gohari MA, Baneshi MR, Zolala F, Garrusi B, Salarpour E, Samari M. Prevalence of domestic violence against women and its visibility in Southeast Iran. Iran J Public Health. 2023;52(3):646.","journal-title":"Iran J Public Health"},{"issue":"2","key":"22784_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.15171\/ijhpm.2016.103","volume":"6","author":"A Nikfarjam","year":"2017","unstructured":"Nikfarjam A, Hajimaghsoudi S, Rastegari A, Haghdoost AA, Nasehi AA, Memaryan N, Tarjoman T, Baneshi MR. The frequency of alcohol use in Iranian urban population: the results of a National network scale up survey. Int J Health Policy Manag. 2017;6(2):97\u2013102.","journal-title":"Int J Health Policy Manag"},{"key":"22784_CR26","unstructured":"Rastegari A, Haghdoost AA, Mehrolhassani MH, Azizian M, Maghsoudim SH, Baneshi MR. How to assess visibility of drug-related stigmatized behaviours? Does the choice of method matter? HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS 2022, 24(4):19\u201325."},{"key":"22784_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.drugpo.2016.01.013","volume":"31","author":"A Nikfarjam","year":"2016","unstructured":"Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, Rastegari A, Nasehi AA, Memaryan N, Tarjoman T. National population size Estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147\u201352.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"22784_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5812\/ircmj.7673","volume":"15","author":"AA Haghdoost","year":"2013","unstructured":"Haghdoost AA, Baneshi MR, Eybpoosh S, Khajehkazemi R. Comparison of three interview methods on response pattern to sensitive and non-sensitive questions. Iran Red Crescent Med J. 2013;15(6):500.","journal-title":"Iran Red Crescent Med J"},{"issue":"8","key":"22784_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.15171\/ijhpm.2018.18","volume":"7","author":"M Nasirian","year":"2018","unstructured":"Nasirian M, Hooshyar SH, Haghdoost AA, Karamouzian M. How and where do we ask sensitive questions: self-reporting of STI-associated symptoms among the Iranian general population. Int J Health Policy Manage. 2018;7(8):738.","journal-title":"Int J Health Policy Manage"},{"issue":"4","key":"22784_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5539\/gjhs.v5n4p217","volume":"5","author":"A Rastegari","year":"2013","unstructured":"Rastegari A, Haji-Maghsoudi S, Haghdoost A, Shatti M, Tarjoman T, Baneshi MR. The Estimation of active social network size of the Iranian population. Glob J Health Sci. 2013;5(4):217\u201327.","journal-title":"Glob J Health Sci"},{"issue":"2","key":"22784_CR31","first-page":"213","volume":"1","author":"N Saghafi-Ameri","year":"2010","unstructured":"Saghafi-Ameri N. The Afghan drugs Problem\u2013A challenge to Iran and international security. Iran Rev Foreign Affairs. 2010;1(2):213\u201335.","journal-title":"Iran Rev Foreign Affairs"},{"issue":"1","key":"22784_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.socnet.2010.10.006","volume":"33","author":"MJ Salganik","year":"2011","unstructured":"Salganik MJ, Mello MB, Abdo AH, Bertoni N, Fazito D, Bastos FI. The game of contacts: estimating the social visibility of groups. Social Networks. 2011;33(1):70\u20138.","journal-title":"Social Networks"},{"key":"22784_CR33","unstructured":"Team RC. R: A Language and environment for statistical computing. R foundation for statistical computing. (No Title) 2013."},{"key":"22784_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-020-00279-1","volume":"15","author":"M Moradinazar","year":"2020","unstructured":"Moradinazar M, Najafi F, Jalilian F, Pasdar Y, Hamzeh B, Shakiba E, Hajizadeh M, Haghdoost AA, Malekzadeh R, Poustchi H. Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a National survey. Subst Abuse Treat Prev Policy. 2020;15:1\u201311.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"22784_CR35","unstructured":"World Drug Report. 2018. United Nations publication Sales No. E.18.XI.9."},{"key":"22784_CR36","unstructured":"World drug report. 2016. United Nations Office on Drugs and Crime."},{"issue":"10","key":"22784_CR37","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/add.13453","volume":"111","author":"M Amin-Esmaeili","year":"2016","unstructured":"Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, Hefazi M, Motevalian A. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey. Addiction. 2016;111(10):1836\u201347.","journal-title":"Addiction"},{"key":"22784_CR38","unstructured":"EMCDDA. European drug report: trends and developments. In.: Publications Office of the European Union Luxembourg; 2019."},{"issue":"6","key":"22784_CR39","doi-asserted-by":"publisher","first-page":"e885","DOI":"10.1002\/hsr2.885","volume":"5","author":"J Hosseini","year":"2022","unstructured":"Hosseini J, Shojaeefar E, Pooladgar P, Aliakbari F, Ganji M, Hamdieh M, Kheradmand A, Fashami MA. Prevalence of substance use among Iranian male adolescents: systematic review and meta-analysis. Health Sci Rep. 2022;5(6):e885.","journal-title":"Health Sci Rep"},{"issue":"1","key":"22784_CR40","doi-asserted-by":"publisher","first-page":"e0190381","DOI":"10.1371\/journal.pone.0190381","volume":"13","author":"G Lauritzen","year":"2018","unstructured":"Lauritzen G, Nordfj\u00e6rn T. Changes in opiate and stimulant use through 10 years: the role of contextual factors, mental health disorders and psychosocial factors in a prospective SUD treatment cohort study. PLoS ONE. 2018;13(1):e0190381.","journal-title":"PLoS ONE"},{"issue":"4","key":"22784_CR41","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/jnu.12486","volume":"51","author":"JE Ryan","year":"2019","unstructured":"Ryan JE, Smeltzer SC, Sharts-Hopko NC. Challenges to studying illicit drug users. J Nurs Scholarsh. 2019;51(4):480\u20138.","journal-title":"J Nurs Scholarsh"},{"key":"22784_CR42","unstructured":"World drug report. 2017. United Nations Office on Drugs and Crime."},{"key":"22784_CR43","first-page":"543","volume":"2","author":"S Momtazi","year":"2015","unstructured":"Momtazi S, Noroozi A, Rawson R. An overview of Iran drug treatment and harm reduction programs. Textbook Addict Treatment: Int Perspect. 2015;2:543\u201354.","journal-title":"Textbook Addict Treatment: Int Perspect"},{"key":"22784_CR44","doi-asserted-by":"crossref","unstructured":"Zafarghandi MBS, Jadidi M, Khalili N. Iran\u2019s activities on prevention, treatment and harm reduction of drug abuse. Int J High Risk Behav Addict 2015, 4(4).","DOI":"10.5812\/ijhrba.22863"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22784-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:06:28Z","timestamp":1777863988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-22784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["22784"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22784-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the Declaration of Helsinki guidelines. The ethical committee of Kerman University of Medical Sciences reviewed and approved the study (Ethics Code: IR.KMU.REC.1397.111). Before enrolling in the study, the purpose of the study was explained to participants. All participants provided verbal informed consent to complete the questionnaires. They were informed that their responses would remain confidential and anonymous, with no real names used to identify them. All research was performed in accordance with relevant regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1452"}}